Company: LENZ
Filing Date: 2025-04-15
Form Type: 8-K
Source: 0001815776-25-000025
Chunk: 0

Company: LENZ Therapeutics, Inc.
Filing Date: 2025-04-15
Form: 8-K
Item: Item 2.02
Chunk 0
---
Item 2.02 Results of Operations and Financial Condition.

LENZ Therapeutics, Inc. (the “ Company”) is filing this Current Report on Form 8-K in connection with the previously announced Commercial Day to be held on April 15, 2025, to announce that the Company’s cash, cash equivalents and marketable securities were approximately $194 million as of March 31, 2025. This amount is unaudited and preliminary and is subject to completion of financial closing procedures. Our independent registered public accounting firm has not audited, reviewed or performed any procedures with respect to these preliminary results and, accordingly, does not express an opinion or any other form of assurance about them.

Item 7.01 Regulation FD Disclosure.